Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.

Theranostics · 2026 · PMC13142127 · PMID 42094596

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Regarding safety, Feng-1 treatment did not significantly affect body weight, spleen weight, or spleen index in mice, and induced a decreasing trend in regulatory T cell (CD4+CD25+Foxp3+) in the spleen. 5.3.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.